The uses for Botox are endless! Or at least that is what it’s manufacturer thinks. It’s no longer just above luscious lips and what not. There are true medical conditions that are benefiting from it’s uses.
Now, Allergan is making its next play to inject more value into Botox. The company has said its Botox met the primary goals of a pair of late stage clinical trials for overactive bladder by significantly reducing episodes of urinary incontinence, creating another potentially lucrative revenue source for the wrinkle treatment.
The company has asked U.S. and European regulators to approve its wrinkle-fighting injection to treat patients with garden-variety overactive bladder, citing two Phase III trials.
It’s a much larger market than Botox’s already approved use to fight incontinence in patients with neurological problems, such as multiple sclerosis. The company estimates that 3.2 million American use oral drugs to fight overactive bladder, and more than half of them stop taking the pills because they either don’t work or cause troublesome side effects, creating a market for Botox.
Who knew this could be such a useful medication.